Healthequity (NASDAQ:HQY) had its price target boosted by SunTrust Banks from $55.00 to $68.00 in a report released on Thursday, The Fly reports. The brokerage currently has a “buy” rating on the stock. SunTrust Banks’ price objective suggests a potential upside of 22.50% from the stock’s current price.

Several other research analysts have also issued reports on HQY. TheStreet upgraded Healthequity from a “c+” rating to a “b-” rating in a research report on Friday, February 21st. Robert W. Baird lowered their target price on shares of Healthequity from $74.00 to $47.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 17th. KeyCorp lowered their price objective on Healthequity from $86.00 to $65.00 and set an “overweight” rating for the company in a research note on Tuesday, March 17th. BidaskClub downgraded Healthequity from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. Finally, Zacks Investment Research downgraded Healthequity from a “buy” rating to a “sell” rating and set a $71.00 price objective for the company. in a research note on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $70.08.

Shares of HQY stock traded up $2.63 during trading hours on Thursday, reaching $55.51. The stock had a trading volume of 8,081 shares, compared to its average volume of 1,489,536. The firm has a market capitalization of $3.54 billion, a PE ratio of 84.32, a price-to-earnings-growth ratio of 1.75 and a beta of 1.31. The company has a debt-to-equity ratio of 1.21, a current ratio of 1.95 and a quick ratio of 1.91. The firm has a 50-day simple moving average of $65.44 and a 200-day simple moving average of $64.43. Healthequity has a twelve month low of $34.40 and a twelve month high of $88.78.

Healthequity (NASDAQ:HQY) last issued its quarterly earnings data on Monday, March 16th. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.16. The firm had revenue of $201.20 million for the quarter, compared to analyst estimates of $199.95 million. Healthequity had a net margin of 7.46% and a return on equity of 10.54%. The company’s revenue for the quarter was up 165.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.21 earnings per share. On average, equities analysts anticipate that Healthequity will post 1.26 earnings per share for the current year.

In related news, VP Ashley Dreier sold 26,993 shares of the stock in a transaction dated Friday, January 24th. The stock was sold at an average price of $71.02, for a total transaction of $1,917,042.86. Following the completion of the sale, the vice president now owns 53,737 shares in the company, valued at $3,816,401.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Darcy G. Mott sold 4,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $72.93, for a total value of $291,720.00. Following the transaction, the chief financial officer now owns 31,801 shares of the company’s stock, valued at approximately $2,319,246.93. The disclosure for this sale can be found here. In the last 90 days, insiders sold 37,413 shares of company stock valued at $2,649,496. Company insiders own 3.70% of the company’s stock.

Several hedge funds have recently modified their holdings of the stock. FMR LLC increased its holdings in Healthequity by 14.7% in the fourth quarter. FMR LLC now owns 3,936,310 shares of the company’s stock valued at $291,562,000 after buying an additional 505,907 shares during the last quarter. Public Employees Retirement System of Ohio grew its position in shares of Healthequity by 13.3% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 103,556 shares of the company’s stock valued at $5,918,000 after buying an additional 12,132 shares during the last quarter. Lenox Wealth Advisors LLC bought a new stake in shares of Healthequity during the 4th quarter valued at about $28,000. Steward Partners Investment Advisory LLC grew its position in Healthequity by 6,073.5% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 26,114 shares of the company’s stock worth $1,934,000 after purchasing an additional 25,691 shares during the last quarter. Finally, California State Teachers Retirement System grew its position in Healthequity by 14.2% in the 3rd quarter. California State Teachers Retirement System now owns 107,928 shares of the company’s stock worth $6,168,000 after purchasing an additional 13,408 shares during the last quarter. 99.08% of the stock is owned by hedge funds and other institutional investors.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading: How to trade on quiet period expirations

The Fly

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.